Z Ahmed, W Mosabbir, D Tandon, SP Pereira… - bioRxiv, 2024 - biorxiv.org
Cell line experiments arguably remain the most used tool in preclinical cancer research,
despite their limitations. With almost 95% drugs entering human trials failing, and up to 90 …